Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Repetitive Behavior Severity as an Early Indicator of Risk for Elevated Anxiety Symptoms in Autism Spectrum Disorder.

Baribeau DA, Vigod S, Pullenayegum E, Kerns CM, Mirena P, Smith IM, Vaillancourt T, Volden J, Waddell C, Zwaigenbaum L, Bennett T, Duku E, Elsabbagh M, Georgiades S, Ungar WJ, Zaidman-Zait A, Szatmari P; Editorial Clinical Guidance.

J Am Acad Child Adolesc Psychiatry. 2019 Sep 18. pii: S0890-8567(19)32014-3. doi: 10.1016/j.jaac.2019.08.478. [Epub ahead of print]

PMID:
31541676
2.

Predictors of longer-term development of expressive language in two independent longitudinal cohorts of language-delayed preschoolers with Autism Spectrum Disorder.

Bal VH, Fok M, Lord C, Smith IM, Mirenda P, Szatmari P, Vaillancourt T, Volden J, Waddell C, Zwaigenbaum L, Bennett T, Duku E, Elsabbagh M, Georgiades S, Ungar WJ, Zaidman-Zait A.

J Child Psychol Psychiatry. 2019 Aug 19. doi: 10.1111/jcpp.13117. [Epub ahead of print]

PMID:
31429087
3.

Examining Trajectories of Daily Living Skills over the Preschool Years for Children with Autism Spectrum Disorder.

Di Rezze B, Duku E, Szatmari P, Volden J, Georgiades S, Zwaigenbaum L, Smith IM, Vaillancourt T, Bennett TA, Elsabbagh M, Thompson A, Ungar WJ, Waddell C; Pathways in ASD Study Team.

J Autism Dev Disord. 2019 Aug 1. doi: 10.1007/s10803-019-04150-6. [Epub ahead of print]

PMID:
31372802
4.

The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing.

Hayeems RZ, Luca S, Ungar WJ, Bhatt A, Chad L, Pullenayegum E, Meyn MS.

Genet Med. 2019 Jul 31. doi: 10.1038/s41436-019-0620-0. [Epub ahead of print]

PMID:
31363181
5.

Environmental scan of Canadian and UK policies for autism spectrum disorder diagnostic assessment.

Penner M, Anagnostou E, Andoni LY, Ungar WJ.

Paediatr Child Health. 2019 Jun;24(3):e125-e134. doi: 10.1093/pch/pxy107. Epub 2018 Aug 3.

PMID:
31110463
6.

Impact of growing up with a sibling with a neurodevelopmental disorder on the quality of life of an unaffected sibling: a scoping review.

Lamsal R, Ungar WJ.

Disabil Rehabil. 2019 May 18:1-9. doi: 10.1080/09638288.2019.1615563. [Epub ahead of print]

PMID:
31106599
7.

Developmental Trajectories of Feeding Problems in Children with Autism Spectrum Disorder.

Peverill S, Smith IM, Duku E, Szatmari P, Mirenda P, Vaillancourt T, Volden J, Zwaigenbaum L, Bennett T, Elsabbagh M, Georgiades S, Ungar WJ.

J Pediatr Psychol. 2019 Sep 1;44(8):988-998. doi: 10.1093/jpepsy/jsz033.

PMID:
31089730
8.

Shifting Priorities for the Survival of My Child: Managing Expenses, Increasing Debt, and Tapping Into Available Resources to Maintain the Financial Stability of the Family.

Tsimicalis A, Stevens B, Ungar WJ, Castro A, Greenberg M, Barr R.

Cancer Nurs. 2019 Apr 3. doi: 10.1097/NCC.0000000000000698. [Epub ahead of print]

PMID:
30950931
9.

Types of Services and Costs of Programs for Preschoolers with Autism Spectrum Disorder Across Sectors: A Comparison of Two Canadian Provinces.

Tsiplova K, Ungar WJ, Flanagan HE, den Otter J, Waddell C, Murray P, D'Entremont B, Léger N, Garon N, Bryson S, Smith IM.

J Autism Dev Disord. 2019 Jun;49(6):2492-2508. doi: 10.1007/s10803-019-03993-3.

PMID:
30937737
10.

Genetic counselors' preferences for coverage of preimplantation genetic diagnosis: A discrete choice experiment.

Goh ES, Miller FA, Marshall DA, Ungar WJ.

Clin Genet. 2019 Jun;95(6):684-692. doi: 10.1111/cge.13531. Epub 2019 Apr 2.

PMID:
30859557
11.

Patterns, trends and methodological associations in the measurement and valuation of childhood health utilities.

Kwon J, Kim SW, Ungar WJ, Tsiplova K, Madan J, Petrou S.

Qual Life Res. 2019 Jul;28(7):1705-1724. doi: 10.1007/s11136-019-02121-z. Epub 2019 Feb 19. Review.

12.

Comparing the 1-year impact of preschool autism intervention programs in two Canadian provinces.

Smith IM, Flanagan HE, Ungar WJ, D'Entremont B, Garon N, den Otter J, Waddell C, Bryson SE, Tsiplova K, Léger N, Vezina F, Murray P.

Autism Res. 2019 Apr;12(4):667-681. doi: 10.1002/aur.2072. Epub 2019 Jan 10.

PMID:
30632299
13.

Gender Differences in Pragmatic Communication in School-Aged Children with Autism Spectrum Disorder (ASD).

Conlon O, Volden J, Smith IM, Duku E, Zwaigenbaum L, Waddell C, Szatmari P, Mirenda P, Vaillancourt T, Bennett T, Georgiades S, Elsabbagh M, Ungar WJ; Pathways in ASD Study Team.

J Autism Dev Disord. 2019 May;49(5):1937-1948. doi: 10.1007/s10803-018-03873-2.

PMID:
30627893
14.

A Cost Analysis of Pulse Oximetry as a Determinant in the Decision to Admit Infants With Mild to Moderate Bronchiolitis.

Mendlowitz AB, Widjaja E, Phan C, Sun Z, Moretti ME, Schuh S, Coyte PC, Hancock-Howard R, Freedman SB, Ungar WJ.

Pediatr Emerg Care. 2018 Dec 27. doi: 10.1097/PEC.0000000000001664. [Epub ahead of print]

PMID:
30601347
15.

Psychometric Properties of the Merrill-Palmer-Revised Scales of Development in Preschool Children With Autism Spectrum Disorder.

Dempsey EE, Smith IM, Flanagan HE, Duku E, Lawrence MA, Szatmari P, Zwaigenbaum L, Vaillancourt T, Volden J, Mirenda P, Wadell C, Georgiades S, Elsabbagh M, Ungar WJ, Bennett T.

Assessment. 2018 Dec 20:1073191118818754. doi: 10.1177/1073191118818754. [Epub ahead of print]

PMID:
30569744
16.

Family Spillover Effects in Pediatric Cost-Utility Analyses.

Lavelle TA, D'Cruz BN, Mohit B, Ungar WJ, Prosser LA, Tsiplova K, Vera-Llonch M, Lin PJ.

Appl Health Econ Health Policy. 2019 Apr;17(2):163-174. doi: 10.1007/s40258-018-0436-0.

PMID:
30350218
17.

Assessing the accuracy of the Modified Checklist for Autism in Toddlers: a systematic review and meta-analysis.

Yuen T, Penner M, Carter MT, Szatmari P, Ungar WJ.

Dev Med Child Neurol. 2018 Nov;60(11):1093-1100. doi: 10.1111/dmcn.13964. Epub 2018 Jul 11. Review.

PMID:
29992541
18.

Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.

Yuen T, Carter MT, Szatmari P, Ungar WJ.

Appl Health Econ Health Policy. 2018 Aug;16(4):481-493. doi: 10.1007/s40258-018-0390-x.

PMID:
29651777
19.

Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder.

Yuen T, Carter MT, Szatmari P, Ungar WJ.

J Autism Dev Disord. 2018 Sep;48(9):2968-2979. doi: 10.1007/s10803-018-3571-4.

PMID:
29644584
20.

Appendectomy versus non-operative treatment for acute uncomplicated appendicitis in children: study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.

Hall NJ, Eaton S, Abbo O, Arnaud AP, Beaudin M, Brindle M, Bütter A, Davies D, Jancelewicz T, Johnson K, Keijzer R, Lapidus-Krol E, Offringa M, Piché N, Rintala R, Skarsgard E, Svensson JF, Ungar WJ, Wester T, Willan AR, Zani A, St Peter SD, Pierro A.

BMJ Paediatr Open. 2017 May 18;1(1). pii: bmjpo-2017-000028. doi: 10.1136/bmjpo-2017-000028. eCollection 2017.

21.

Practice patterns and determinants of wait time for autism spectrum disorder diagnosis in Canada.

Penner M, Anagnostou E, Ungar WJ.

Mol Autism. 2018 Mar 6;9:16. doi: 10.1186/s13229-018-0201-0. eCollection 2018.

22.

Assessing care-giving demands, resources and costs of family/friend caregivers for persons with mental health disorders: A scoping review.

Lin E, Durbin J, Guerriere D, Volpe T, Selick A, Kennedy J, Ungar WJ, Lero DS.

Health Soc Care Community. 2018 Mar 1. doi: 10.1111/hsc.12546. [Epub ahead of print] Review.

PMID:
29498120
23.

Correction to: Profiles of Social and Coping Resources in Families of Children with Autism Spectrum Disorder: Relations to Parent and Child Outcomes.

Zaidman-Zait A, Mirenda P, Szatmari P, Duku E, Smith IM, Vaillancourt T, Volden J, Waddell C, Bennett T, Zwaigenbaum L, Elsabaggh M, Georgiades S, Ungar WJ; Pathways in ASD Study Team.

J Autism Dev Disord. 2018 Jun;48(6):2077. doi: 10.1007/s10803-018-3498-9.

PMID:
29450834
24.

Profiles of Social and Coping Resources in Families of Children with Autism Spectrum Disorder: Relations to Parent and Child Outcomes.

Zaidman-Zait A, Mirenda P, Szatmari P, Duku E, Smith IM, Vaillancourt T, Volden J, Waddell C, Bennett T, Zwaigenbaum L, Elsabaggh M, Georgiades S, Ungar WJ; Pathways in ASD Study Team.

J Autism Dev Disord. 2018 Jun;48(6):2064-2076. doi: 10.1007/s10803-018-3467-3. Erratum in: J Autism Dev Disord. 2018 Feb 15;:.

PMID:
29362954
25.

COST ANALYSIS OF PERIPHERALLY INSERTED CENTRAL CATHETER IN PEDIATRIC PATIENTS.

Dong Z, Connolly BL, Ungar WJ, Coyte PC.

Int J Technol Assess Health Care. 2018 Jan;34(1):38-45. doi: 10.1017/S026646231700109X. Epub 2017 Dec 20.

PMID:
29258628
26.

The Impact of a Childhood Cancer Diagnosis on the Children and Siblings' School Attendance, Performance, and Activities: A Qualitative Descriptive Study.

Tsimicalis A, Genest L, Stevens B, Ungar WJ, Barr R.

J Pediatr Oncol Nurs. 2018 Mar/Apr;35(2):118-131. doi: 10.1177/1043454217741875. Epub 2017 Dec 1.

PMID:
29192538
27.

Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.

Hayeems RZ, Bhawra J, Tsiplova K, Meyn MS, Monfared N, Bowdin S, Stavropoulos DJ, Marshall CR, Basran R, Shuman C, Ito S, Cohn I, Hum C, Girdea M, Brudno M, Cohn RD, Scherer SW, Ungar WJ.

Eur J Hum Genet. 2017 Dec;25(12):1303-1312. doi: 10.1038/s41431-017-0020-3. Epub 2017 Nov 20.

28.

A Systematic Review and Meta-analysis of Childhood Health Utilities.

Kwon J, Kim SW, Ungar WJ, Tsiplova K, Madan J, Petrou S.

Med Decis Making. 2018 Apr;38(3):277-305. doi: 10.1177/0272989X17732990. Epub 2017 Oct 7.

PMID:
28990449
29.

Public drug policy for children in Canada.

Denburg AE, Ungar WJ, Greenberg M.

CMAJ. 2017 Jul 31;189(30):E990-E994. doi: 10.1503/cmaj.170380. Review. No abstract available.

30.

A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.

Moretti ME, Lato DF, Berger H, Koren G, Ito S, Ungar WJ.

Pharmacogenomics J. 2018 May 22;18(3):391-397. doi: 10.1038/tpj.2017.33. Epub 2017 Jul 11.

PMID:
28696420
31.

Systematic review of clinical guidance documents for autism spectrum disorder diagnostic assessment in select regions.

Penner M, Anagnostou E, Andoni LY, Ungar WJ.

Autism. 2018 Jul;22(5):517-527. doi: 10.1177/1362361316685879. Epub 2017 May 26.

32.

Genetic Testing among Children in a Complex Care Program.

Oei K, Hayeems RZ, Ungar WJ, Cohn RD, Cohen E.

Children (Basel). 2017 May 22;4(5). pii: E42. doi: 10.3390/children4050042.

33.

A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.

Tsiplova K, Zur RM, Marshall CR, Stavropoulos DJ, Pereira SL, Merico D, Young EJ, Sung WWL, Scherer SW, Ungar WJ.

Genet Med. 2017 Nov;19(11):1268-1275. doi: 10.1038/gim.2017.47. Epub 2017 May 4.

PMID:
28471434
34.

Systematic review of the cost-effectiveness of influenza immunization programs.

Ting EEK, Sander B, Ungar WJ.

Vaccine. 2017 Apr 4;35(15):1828-1843. doi: 10.1016/j.vaccine.2017.02.044. Epub 2017 Mar 9. Review.

PMID:
28284681
35.

Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.

Luca NJ, Burnett HF, Ungar WJ, Moretti ME, Beukelman T, Feldman BM, Schwartz G, Bayoumi AM.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1803-1811. doi: 10.1002/acr.22903. Epub 2016 Oct 21.

36.

A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?

Sullivan SM, Tsiplova K, Ungar WJ.

Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):599-607. Review.

PMID:
27659998
37.

Maximizing the Benefit and Mitigating the Risks of Moral Hazard.

Zlotnik Shaul R, Ungar WJ.

Am J Bioeth. 2016 Jul;16(7):44-6. doi: 10.1080/15265161.2016.1180456. No abstract available.

PMID:
27292849
38.

Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.

Zur RM, Roy LM, Ito S, Beyene J, Carew C, Ungar WJ.

Pharmacogenomics J. 2016 Aug;16(4):305-11. doi: 10.1038/tpj.2016.37. Epub 2016 May 24. Review.

39.

A further examination of the problem of double-counting in incremental cost-utility analyses.

Ungar WJ.

Expert Rev Pharmacoecon Outcomes Res. 2016 Jun;16(3):333-5. doi: 10.1080/14737167.2016.1182865. Epub 2016 May 9. No abstract available.

PMID:
27113196
40.

Change of Outcomes in Pediatric Intestinal Failure: Use of Time-Series Analysis to Assess the Evolution of an Intestinal Rehabilitation Program.

Oliveira C, de Silva NT, Stanojevic S, Avitzur Y, Bayoumi AM, Ungar WJ, Hoch JS, Wales PW.

J Am Coll Surg. 2016 Jun;222(6):1180-1188.e3. doi: 10.1016/j.jamcollsurg.2016.03.007. Epub 2016 Mar 18.

PMID:
27067452
41.

Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.

Roy LM, Zur RM, Uleryk E, Carew C, Ito S, Ungar WJ.

Pharmacogenomics. 2016 Apr;17(6):633-56. doi: 10.2217/pgs.16.12. Epub 2016 Mar 29.

42.

Patients' Values Related to Treatment Options for Teeth with Apical Periodontitis.

Azarpazhooh A, Dao T, Ungar WJ, Da Costa J, Figueiredo R, Krahn M, Friedman S.

J Endod. 2016 Mar;42(3):365-70. doi: 10.1016/j.joen.2015.11.022. Epub 2016 Jan 6.

PMID:
26778269
43.

The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada.

Bashir NS, Ungar WJ.

Genome. 2015 Dec;58(12):527-40. doi: 10.1139/gen-2015-0100. Epub 2015 Nov 13.

PMID:
26623513
44.

Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design.

Ungar WJ, Hadioonzadeh A, Najafzadeh M, Tsao NW, Dell S, Lynd LD.

BMC Pulm Med. 2015 Nov 17;15:146. doi: 10.1186/s12890-015-0141-9.

45.

National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology Assessment.

Payakachat N, Tilford JM, Ungar WJ.

Pharmacoeconomics. 2016 Feb;34(2):127-38. doi: 10.1007/s40273-015-0331-6.

46.

Next Generation Sequencing and Health Technology Assessment in Autism Spectrum Disorder.

Ungar WJ.

J Can Acad Child Adolesc Psychiatry. 2015 Fall;24(2):123-7. Epub 2015 Aug 31.

47.

Cost-effectiveness analysis of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures.

Burnett HF, Lambley R, West SK, Ungar WJ, Mireskandari K.

Br J Ophthalmol. 2015 Nov;99(11):1565-70. doi: 10.1136/bjophthalmol-2015-306604. Epub 2015 May 6.

PMID:
25947558
48.

Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis.

Burnett HF, Ungar WJ, Regier DA, Feldman BM, Miller FA.

Value Health. 2014 Dec;17(8):830-7. doi: 10.1016/j.jval.2014.08.2668. Epub 2014 Nov 6.

49.

Testing for thiopurine methyltransferase status for safe and effective thiopurine administration: a systematic review of clinical guidance documents.

Burnett HF, Tanoshima R, Chandranipapongse W, Madadi P, Ito S, Ungar WJ.

Pharmacogenomics J. 2014 Dec;14(6):493-502. doi: 10.1038/tpj.2014.47. Epub 2014 Aug 26. Review.

PMID:
25156214
50.

An emerging field of research: challenges in pediatric decision making.

Lipstein EA, Brinkman WB, Fiks AG, Hendrix KS, Kryworuchko J, Miller VA, Prosser LA, Ungar WJ, Fox D.

Med Decis Making. 2015 Apr;35(3):403-8. doi: 10.1177/0272989X14546901. Epub 2014 Aug 21. Review.

Supplemental Content

Loading ...
Support Center